ACXP·00510M104·UQ·equity·Healthcare - Biotechnology-13D/G
ACXP (Acurx Pharmaceuticals, Inc.) is held by 13 institutional investors as of Q4 2025. Largest holders: MILLENNIUM MANAGEMENT LLC ($103,153), VANGUARD GROUP INC ($57,967), NORTHERN TRUST CORP ($42,116). Net institutional sentiment: Mixed.
See how ACXP's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer